Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Reproductive system and breast disorders – page 82

  • 973 clinical trials
  • 383 recruiting
  • 347 conditions
  • 28 countries

Conditions in this area

347 conditions with trials, the busiest first

Breast cancer176Prostate cancer104Ovarian cancer91Breast cancer metastatic85Triple negative breast cancer70Hormone receptor positive HER2 negative breast cancer67Hormone-refractory prostate cancer58Endometrial cancer53Prostate cancer metastatic49HER2 positive breast cancer43Hormone receptor positive breast cancer43Cervix carcinoma35Fallopian tube cancer30Breast cancer female27Non-small cell lung cancer26Infertility female22Hormone-dependent prostate cancer19Infertility19Ovarian cancer recurrent18Ovarian epithelial cancer18Neoplasm14Colorectal cancer13Gastric cancer13Head and neck cancer12+323

Clinical trials in Reproductive system and breast disorders

973 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

973 clinical trials

Hormone-refractory prostate cancer

Not recruiting

Study of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Opevesostat
  • Sponsor:Orion Corporation

Substances studied in this area

The therapies tested most often in Reproductive system and breast disorders trials.

Paclitaxel120 clinical trialsCarboplatin87 clinical trialsLetrozole76 clinical trialsPembrolizumab76 clinical trialsFulvestrant61 clinical trialsDocetaxel51 clinical trialsEnzalutamide51 clinical trialsExemestane48 clinical trialsAnastrozole46 clinical trials
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.